Found 606 clinical trials
A Study of TAK-341 in Treatment of Multiple System Atrophy
The main aim is to see how TAK-341 works after 52 weeks in participants with multiple system atrophy as measured by the Unified Multiple System Atrophy Rating Scale Part I (UMSARS).
- 9 views
- 14 Dec, 2022
- 1 location
Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial
of vaginal atrophy in menopausal women living with HIV.
- 79 views
- 03 Mar, 2021
- 1 location
Proteins and Brain Networks in Atypical Alzheimer's Disease
Participants will take part in 2-4 study visits including detailed history and neurological exam, pen-&-paper cognitive testing, and functional MRI and PET scans designed to help us understand how different forms of Alzheimer's disease affect brain circuits over time.
- 53 views
- 24 Jan, 2022
- 1 location
Vascular Contributions to Mechanisms and Biomarkers of Alzheimer’s Disease
This study is managed by Temple University Alzheimer’s Center in collaboration with Crozer Keystone Health System. NO drug involvedThe study will evaluate longitudinally whether the presence of cardiovascular (CV) risk factors (particularly hypertension and hyperhomocysteinemia), in an age and gender-matched population including cognitive normal, subjects with mild cognitive impairment (MCI) …
- 16 views
- 09 Sep, 2022
- 1 location
New Approaches to Dementia Heterogeneity.
This study is looking for adults who have mild cognitive impairment, Alzheimer’s, or other forms of dementia. The study is also looking for people with normal cognition, as a comparison. The study is interested in the ways that brain function changes over time with the goal of improving the ability to diagnose …
- 160 views
- 25 May, 2021
- 1 location
Study to Evaluate the Safety and Efficacy of Tinlarebant in the Treatment of Stargardt Disease in Adolescent Subjects Lesion(s) in Adolescent Subjects With STGD1
The primary objective of this trial is to assesses the efficacy of tinlarebant in slowing the rate of growth of atrophic lesion(s) in adolescent subjects with STGD1
- 0 views
- 04 Oct, 2022
- 6 locations
A Randomized, Sham-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Intrathecal OAV101 in Type 2 Spinal Muscular Atrophy (SMA) Patients Who Are ≥ 2 to < 18 Years of Age, Treatment Naive, Sitting, and Never Ambulatory (STEER)
To evaluate the efficacy, safety and tolerability of intrathecal (IT) OAV101 in treatment naive patients with Type 2 spinal muscular atrophy (SMA) who are ≥ 2 to < 18 years of age over a 15
- 4 views
- 24 Oct, 2022
- 11 locations
Different Endoscopic Gastric Cancer Risk Assessments
The Kimura-Takamoto classification established in Japan can observe the extent of gastric atrophy in real-time under endoscopy, and diffuse atrophy also indicates an increased risk of gastric
- 0 views
- 04 Oct, 2022
- 1 location
A Study of Nusinersen Among Participants With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec (RESPOND)
The primary objective of this study is to evaluate the clinical outcomes following treatment with nusinersen in participants with spinal muscular atrophy (SMA) who previously received
- 2 views
- 07 Oct, 2022
- 20 locations